OXYTOCIC PHARMACEUTICALS MARKET ANALYSIS

Oxytocic Pharmaceuticals Market, By Indication (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Hemorrhage, Labor Induction, and Labor Arrest), By Route of Administration (Intramuscular, and Intravenous Injection/Infusion), By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin (Animal Pituitary Extract)), By End User (Hospitals, and Maternity Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

Published In : Jun 2023
Code : CMI3354
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Oxytocic Pharmaceuticals Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global oxytocic pharmaceuticals market over the forecast period due to increasing number of preterm births, fertility rates, and increasing healthcare expenditure. North America is estimated to hold 47.5% of the market share in 2023. For instance, according to the Centers for Disease Control and Prevention (CDC), “Births: Provisional Data for 2021” report, the number of births in the United States and the general fertility rate increased for the first time in seven years in 2021. The report shows a 1% increase in births from 2020, with 3,659,289 births recorded in 2021. As per the same source, the preterm birth rate rose 4% in 2021 to 10.48%, from 10.09% in 2020.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa